12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Resverlogix completes debt financing

Resverlogix Corp. (TSX:RVX), Calgary, Alberta
Business: Cardiovascular, Neurology, Endocrine/Metabolic
Date completed: 3/11/13
Type: Debt financing
Raised: C$13.8 million ($13.4 million)
Investor: Citibank
Note: Resverlogix drew down...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >